Optain Health develops non-invasive clinical support tools that utilize AI-enabled algorithms to analyze retinal images for disease screening and health evaluation.

Optain Health

Optain | 401 followers on LinkedIn. Optain uses advanced AI retinal imaging to non-invasively assess patient health. | Optain is a medical device and software company based in New York City and with roots in Australia. We are innovating to set the new benchmark in accurate and efficient patient care. We empower people with advanced AI and automation, using the eye as the gateway to detect and prevent diseases in their earliest stages.

CEO - Optain

Jeff Dunkel

Clinical Research Leadership- Diagnostics and Medical Devices

Alejandra Maciel

Managing Director and Cofounder

Jason Sun

President at Optain, Physician

Zachary Tan

Optain

Optain Resolve has been selected as a finalist in Fierce Healthcare 's Innovation Award and we couldn’t be more thrilled! It is our honor to be recognized alongside some of the top trailblazers in the industry. Follow along on our journey as we revolutionize ways to make early detection more accessible across the country through Oculomics and AI. #FierceHealthcareAwards #FierceInnovationAwards https://lnkd.in/gYRKq67k

We are honored to be recognized in the 2024 New York Digital Health 100. This is a testament to the dedication of our New York, Melbourne, and globally-based team, and reinforces our commitment to democratizing access to care via our revolutionary oculomics and AI platform.

OPTA

COM:OPTAINHEALTH

Optain Health